To a solution of sceptrin•2TFA (100 mg, 0.118 mmol) in H2O/CH3CN (1:1, 20 ml) was added peracetic acid solution (In dilute AcOH, 0.024 mmol) and the resulting solution was heated at 50°C. The reaction mixture was monitored by HPLC and additional 5 μL portions of peracetic acid solution added as necessary until ~50% of sceptrin was converted to the dihydroxylated products. The reaction was then stopped. The four isomers of 50 were visible by analytical HPLC. As all four isomers participated in further reactions, they were isolated together by preparative HPLC to give 52 mg of 50 as a white solid (50 % yield) along with 35 mg of recovered sceptrin (35%).
Dihydroxylated sceptrin 50 (15 mg, 0.017 mmol) was dissolved in H2O (3 mL) and 0.2 mL of glacial acetic acid was added. The resulting solution was heated at 140 °C for 1 hour under reflux. The resulting mixture was purified by preparative reverse phase HPLC. Oxysceptrin (13) was obtained as a white solid. (9.5 mg, 65 % yield)
IR (film) νmax 3500-3100, 1735, 1676, 1203, 1139 cm-1; 1H-NMR (600 MHz, CD3OD) δ6.94 (S, 2H), 6.82 (d, 1H), 6.73 (d, 1H), 6.54 (s, 1H), 4.43 (d, 1H), 3.42-3.49 (m, 4H), 3.01 (t, 1H), 2.66 (dt, 1H), 2.25 (m, 2H); 13C-NMR (600 MHz, CD3OD) δ123.0, 97.6, 113.8, 127.3, 127.0, 163.1, 163.0, 43.2, 42.6, 42.1, 41.8, 45.8, 40.0, 43.9, 35.1, 32.9, 61.7, 61.0, 129.1, 128.7, 160.5, 160.4, 148.7, 174.1, 110.6, 110.5; ESI-MS m/z 635, 637, 639 [M+H]+, HRMS (ESI-TOF) calcd. For C22H25Br2N10O3 [M+H+] 635.0472, found 635.0461. |